| Coda Minerals Ltd (COD) ORDINARY FULLY PAID |
Materials |
$52 |
Sydney RIU Conference Presentation
|
7 May 2025 8:51AM |
$0.076 |
$0.140 |
risen by
84.21%
|
|
| Pepper Money Limited (PPM) ORDINARY FULLY PAID |
Financials |
$779 |
Annual General Meeting - Presentation
|
7 May 2025 8:51AM |
$1.620 |
$1.735 |
risen by
7.10%
|
|
| Kalamazoo Resources Limited (KZR) ORDINARY FULLY PAID |
Materials |
$50 |
KZR Renews Victorian Focus on Gold-Antimony Exploration
|
7 May 2025 8:49AM |
$0.085 |
$0.160 |
risen by
89.35%
|
|
| Saunders International Limited (SND) ORDINARY FULLY PAID |
Industrials |
$114 |
Director Appointment/Resignation
|
7 May 2025 8:49AM |
$0.815 |
$0.820 |
risen by
0.61%
|
|
| Bastion Minerals Limited (BMO) ORDINARY FULLY PAID |
Materials |
- |
Quarterly Activities/Appendix 5B Cash Flow Report
|
7 May 2025 8:48AM |
$0.003 |
$0.051 |
risen by
1,600%
|
|
BMO - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration activities focused on Capote, Garin, and Cometa Projects in Chile
- Continued geological mapping, sampling, and drill preparation
- Corporate development and engagement with third parties for potential partnerships
- Review of new project opportunities in line with company strategy
- Detailed cash outflows for exploration and administration provided in Appendix 5B
- No mining production or development activities occurred during the quarter
- Compliance with ASX Listing Rule 5.3.1, 5.3.2, and 5.3.5 requirements
- Commitment to responsible exploration and stakeholder engagement reaffirmed
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$879 |
Update - Notification of buy-back - AOV
|
7 May 2025 8:44AM |
$7.900 |
$6.570 |
fallen by
16.84%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$447 |
Update - Notification of buy-back - PE1
|
7 May 2025 8:42AM |
$1.105 |
$1.675 |
risen by
51.58%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$294 |
Notification of cessation of securities - AMH
|
7 May 2025 8:42AM |
$1.065 |
$0.930 |
fallen by
12.68%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,450 |
2025 AGM - Proxy Summary
|
7 May 2025 8:42AM |
$5.010 |
$5.290 |
risen by
5.59%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,450 |
2025 AGM - CEO's Address
|
7 May 2025 8:42AM |
$5.010 |
$5.290 |
risen by
5.59%
|
|
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$456 |
CUV recruits 200 patients in Phase III vitiligo trial CUV105
|
7 May 2025 8:41AM |
$11.300 |
$9.040 |
fallen by
20%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clinuvel Pharmaceuticals Limited reached the recruitment target of 200 patients for its Phase III trial (CUV105) on vitiligo.
- The CUV105 study is evaluating afamelanotide as a potential repigmentation therapy for vitiligo patients in North America.
- Vitiligo is a chronic skin disorder causing loss of pigmentation, affecting millions globally.
- The trial will assess both efficacy and safety endpoints of the treatment.
- Successful recruitment is a critical milestone enabling progress toward regulatory submission.
- There remains a significant unmet medical need for effective vitiligo treatments.
- Clinuvel sees this achievement as advancing its leadership in therapies for chronic and rare skin disorders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Santos Limited (STO) ORDINARY FULLY PAID |
Energy |
$25,300 |
2025 Santos Macquarie Conference Presentation
|
7 May 2025 8:41AM |
$5.880 |
$7.790 |
risen by
32.48%
|
|
| Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$7 |
Notice of General Meeting/Proxy Form
|
7 May 2025 8:41AM |
$0.007 |
$0.054 |
risen by
671.43%
|
|
| Helia Group Limited (HLI) ORDINARY FULLY PAID |
Financials |
$1,450 |
2025 AGM - Chair's Address
|
7 May 2025 8:40AM |
$5.010 |
$5.290 |
risen by
5.59%
|
|
| Singular Health Group Ltd (SHG) ORDINARY FULLY PAID |
Health Care |
$70 |
Exercise of Options and Cleansing Statement
|
7 May 2025 8:39AM |
$0.295 |
$0.220 |
fallen by
25.42%
|
|
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
Evaluation of Strategic Options Update
|
7 May 2025 8:38AM |
$0.100 |
$0.022 |
fallen by
78%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- MedAdvisor Limited completed a formal strategic review of MedAdvisor US (MDR US).
- The company decided to retain MDR US within the group after evaluating all strategic options.
- MDR US demonstrated strong business performance and strategic fit with MedAdvisor’s long-term objectives.
- The Board highlighted improved operational results and growth prospects for the subsidiary.
- No sale or divestment will proceed for MDR US at this time.
- Leadership and management of MDR US received positive acknowledgment for delivering results.
- The company will focus on organic growth, operational improvements, and maximizing shareholder value.
- The Board thanked stakeholders for their support and reaffirmed commitment to the current strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$43 |
High-Grade Copper Massive Sulphides at Gulf Creek
|
7 May 2025 8:38AM |
$0.037 |
$0.165 |
risen by
345.95%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- OD6 Metals Limited discovered high-grade copper massive sulphides at Gulf Creek, NSW.
- Initial drilling program included six reverse circulation holes.
- Significant copper mineralisation intersected, with grades up to 19% Cu.
- Copper mineralisation is associated with silver and gold.
- Presence of massive and semi-massive sulphides confirmed.
- Results validate historical copper production and geological models.
- Further exploration work planned, including geophysical surveys and follow-up drilling.
- Exploration results support potential for resource growth at Gulf Creek.
- Announcement details exploration strategy and key technical findings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$722 |
Applications, Redemptions, Units on Issue and OTC 30.4.2025
|
7 May 2025 8:37AM |
$1.025 |
$1.045 |
risen by
1.95%
|
|
| Franklin Global Growth Fund (Managed Fund) (FRGG) |
Financials |
$210 |
Applications, Redemptions, Units on Issue and OTC 30.4.2025
|
7 May 2025 8:37AM |
$2.310 |
$1.875 |
fallen by
18.83%
|
|
| CI Resources Limited (CII) ORDINARY FULLY PAID |
Materials |
$149 |
Applications, Redemptions, Units on Issue and OTC 30.4.2025
|
7 May 2025 8:37AM |
$1.285 |
$1.285 |
fallen by
0%
|
|
| Boss Energy Ltd (BOE) ORDINARY FULLY PAID |
Energy |
$666 |
Macquarie Australia Conference Presentation
|
7 May 2025 8:37AM |
$3.540 |
$1.605 |
fallen by
54.66%
|
|
BOE - Price-sensitive ASX Announcement
Full Release
Key Points
- Boss Energy Ltd presented at the Macquarie Australia Conference in May 2024.
- The company is focused on the development and operation of the Honeymoon Uranium Project located in South Australia.
- Honeymoon is one of only four uranium mines in Australia and recently re-commenced production.
- Boss Energy emphasizes its strong financial position with no debt and significant cash reserves.
- The company aims to become a leading global uranium producer and supplier amid growing demand for nuclear energy.
- Significant investment has been made in upgrading the Honeymoon plant and expanding its capacity.
- Boss highlights growing global interest and demand for uranium due to geopolitical supply risks and the energy transition push.
- Macquarie Australia Conference was used as a platform to update investors on operational progress and future plans.
- The company is committed to ESG principles, with a focus on safety, environmental responsibility, and community engagement.
- Boss Energy’s strategy involves targeting further resource exploration and production ramp-up to meet market demands.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ventia Services Group Limited (VNT) ORDINARY FULLY PAID |
Industrials |
$4,410 |
Update - Notification of buy-back - VNT
|
7 May 2025 8:34AM |
$4.440 |
$5.370 |
risen by
20.95%
|
|
| Tesoro Gold Ltd (TSO) ORDINARY FULLY PAID |
Materials |
$192 |
Investor Presentation
|
7 May 2025 8:34AM |
$0.027 |
$1.070 |
risen by
3,862.96%
|
|
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$15 |
OncoSil Outperforms SBRT in Pancreatic Cancer Outcomes
|
7 May 2025 8:33AM |
$0.004 |
$0.485 |
risen by
12,025%
|
|
| Lake Resources NL (LKE) ORDINARY FULLY PAID |
Materials |
$229 |
Strategic Alternatives Announcement
|
7 May 2025 8:33AM |
$0.033 |
$0.099 |
risen by
200%
|
|
LKE - Price-sensitive ASX Announcement
Full Release
Key Points
- Lake Resources NL has initiated a strategic review process to maximize shareholder value.
- JP Morgan has been appointed as the financial advisor for the review.
- Strategic alternatives being explored include sale of the company, sale of assets, joint ventures, strategic investments, or continuing current operations.
- No decisions have yet been made regarding the outcome of the review.
- The Kachi Lithium Brine Project remains a central asset under consideration.
- Operations will continue as normal during the review process.
- Stakeholders will be kept informed with further updates as the process progresses.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
